欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2179/001
药品名称
Vancomicina Kabi
活性成分
vancomycin hydrochloride 500.0 mg
剂型
Powder for infusion*
上市许可持有人
Fresenius Kabi Pharma Portugal, Lda
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Greece (GR)
Iceland (IS)
France (FR)
Germany (DE)
Vancomycin Kabi 500 mg Pulver für eine Infusionslösung
Denmark (DK)
Belgium (BE)
Vancomycine Fresenius Kabi
Luxembourg (LU)
Ireland (IE)
Poland (PL)
Vancomycin Kabi
Latvia (LV)
Vancomycin Kabi 500 mg pulveris infūziju šķīduma koncentrāta pagatavošanai
Lithuania (LT)
Vancomycin Kabi 500 mg milteliai infuzinio tirpalo koncentratui
Estonia (EE)
VANCOMYCIN KABI 500MG
Hungary (HU)
VANCOMYCIN KABI 500 mg por oldatos infúzióhoz való koncentrátumhoz
Czechia (CZ)
Vancomycin Kabi
Romania (RO)
Vancomicina Kabi 500 mg pulbere pentru concentrat pentru solutie perfuzabila
Slovakia (SK)
Vancomycin Kabi 500 mg
Slovenia (SI)
Vankomicin Kabi 500 mg in 1000 mg prašek za koncentrat za raztopino za infundiranje
许可日期
2011/01/18
最近更新日期
2024/04/16
药物ATC编码
J01XA01 vancomycin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
Day_120-Quality AR _NRIM Vancomycin
Date of last change:2011/12/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase